Coronapod: the open-science plan to unseat big Pharma and tackle vaccine inequity
Nature Podcast
00:00
How Fast Is That Happening?
There are scientists who want to see this shared. There is kind of like a column of challenges that are challenges but duable. The w h o thought about, what is the regulatory system like in these countries and they're helping them ramp up. Right now afrgen was aiming to have its new facility for manufacturing human veccines approved by like, the end of this year,. But i've just heard they've had some issues in getting turn ad pieces of equipment. Things are back ordered, supply chain issues. So they're now thinking it might have to be not until early next year.
Transcript
Play full episode
